Molly sells NKTR 13.9: Nektar Therapeutics Given Average Rating of âBuyâ by Brokerages (NASDAQ:NKTR)

Shares of Nektar Therapeutics (NASDAQ:NKTR) have been given an average rating of âBuyâ by the ten brokerages that are currently covering the stock, StockRatingsNetwork.com reports. One research analyst has rated the stock with a sell rating, one has .. ...

18 people liked this